ClinicalTrials.gg
RecruitingNCT07391540Updated Feb 6, 2026

ICBT for Psychological Symptoms Related to Economy

An interventional study of Internet-based cognitive behavioral therapy in Depression and Anxiety Symptom, sponsored by Linkoeping University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Linkoeping University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Depression by Linkoeping University — 4 open to participants now, 7 under way, none of them phase 3. Depression · Linkoeping University.

Planned enrollment
23rd of 27
50 · median 81
Started
2026
the only one that year
No phase
26 of 29
4 open now
Registered
29th of 29
by date

Among the 29 studies in Depression by Linkoeping University, this one is the 23rd largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2026, is one of 26 with no phase, and was the 29th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

4 of the 29 studies in Depression by Linkoeping University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Depression by Linkoeping University, or all of them as a file.
02

Study summary

This study aims to investigate the effects of guided internet-based cogitive behavioral therapy (ICBT) on psychological symptoms related to economy. In this pilot study, the investigators investigate participants' psychological symptoms before and after, and one and two years after, they have received eight weeks of therapist guided ICBT.

Read the detailed description

The treatment the investigators investigate has been developed from earlier treatments used in studies that have shown to be effective for symptoms of depression, anxiety, and stress, among others. Participants will in this pilot study undergo ICBT with weekly guidance by a therapist and in a within-group design, the investigators will compare their self-reported psychological symptoms from before and after the treatment. A one- and two-year follow-up are also planned.

03

Conditions studied

  • Depression and Anxiety Symptom

Keywords

  • Internet-based cognitive behavioral therapy (ICBT)
  • Psychological treatment
  • Economy
  • Depression
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Experience mild to moderate psychological symptoms or problems related to economy
  • 18 years or older
  • Ability to speak, read and write in Swedish
  • Have access to the internet and a smartphone, computer or other device

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric or somatic illness that makes participation harder or impossible
  • Ongoing addiction
  • Acute suicidality
  • Other ongoing psychological treatment
  • Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Treatment group

    All included participants will undergo eight weeks of ICBT with weekly support by a therapist.

    Behavioral: Internet-based cognitive behavioral therapy

Interventions

  • BehavioralInternet-based cognitive behavioral therapy

    The treatment consists of eight treatment modules that the participants receive, one module each week in eight weeks. The modules consists of texts, pictures and interactive exercises. The participants also get weekly guidance by a therapist and they can contact their therapist during the week if needed.

    Also known as: ICBT

06

What researchers measure

Primary outcomes

  1. InCharge Financial Distress/Financial Well-Being Scale

    The InCharge Financial Distress/Financial Well-Being Scale is a measure aiming to measure distress related to the individual's economic situation. It contains of eight questions where the respondent gets to answer on a scale from 1 to 10. This score is then divided by eight (number of questions) and total score is between 1 and 8. A higher score indicates better financial well-being.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  2. Mongomery-Asberg Depression Rating Scale - Självrapportering

    The Mongomery-Asberg Depression Rating Scale - Självrapportering is a self-report questionnaire that aim to measure symptoms of depression. It consists of 9 items and the repondent answers on a scale from 0 to 6. Scoring range is between 0-54. A higher score indicates more (severe) depression symptoms.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  3. Generalized Anxiety Scale-7 item scale

    The Generalized Anxiety Scale-7 item scale aim to measure anxiety symptoms and worry. When summing the points of the seven first questions, the scores are interpreted as mild, moderate and severe anxiety symptoms at 5-10, 11-15 and above 15 respectively. Thus, a higher score indicates higher levels of anxiety and worry. Total score range is between 0 and 21.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

Secondary outcomes

  1. Perceived Stress Scale-14

    The Perceived Stress Scale-14 is a questionnaire that aims to measure symptoms of stress. I contains 14 items that are scored on a range betewwn 0 (never) to 4 (very often). The total score range is between 0-56 and a higher score reflects higher levels of perceived stress.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  2. Insomnia Severity Index

    The Insomnia Severity Index is a measure of insomnia severity and symptoms of disordered sleep. Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), and severe sleep problems (22 to 28 points). Thus, a higher score indicates more symptoms of insomnia. The score range is between 0 and 28.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  3. Brunnsviken Brief Quality of Life Scale

    The Brunnsviken Brief Quality of Life Scale is a measure of quality of life with a total score ranging from 0 to 96, with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied by the score of an item measuring the perceived importance of the area in question.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  4. Goldberg's (1999) International Personality Item Pool representation of Costa McCrae's (1992) Neuroticism-Extraversion-Openness Personality Inventory - Revised Domains

    The Goldberg's (1999) International Personality Item Pool representation of Costa McCrae's (1992) Neuroticism-Extraversion-Openness Personality Inventory - Revised Domains is a measure of neuroticism. It consists of 10 items, scored from 0 (Very inaccurate) to 4 (Very accurate). A higher score indicates neurotic traits to a greater extent. The total score ranges from 0 to 40.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  5. Rosenberg's Self-esteem Scale

    The Rosenberg's Self-esteem Scale is a measure of self-esteem, consisting of ten items where five of them are positively and five of them are negatively worded. Sum scores range between 0 and 30. A higher score indicates higher self-esteem.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

Other outcomes

  1. Alcohol Use Disorder Identification Test

    The Alcohol Use Disorder Identification Test is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. 10 items and scores ranging from 0-40, with higher scores indicating a higher level of alcohol use.

    Time frame: This measure was only used for screening purpose and was thus not included in the result analysis. Thus, it was only used at baseline.

  2. Knowledge test (created by the research team)

    The knowledge test is a test about cognitive behavior therapy and how strategies in cognitive behavior therapy can be applied in everyday situations. It consists of 16 questions, and the respondent gets three answer options, with one of the alternatives being correct. The respondents also answer whether they are guessing/quite certain/entirely sure of their answer. The total score ranges between 0 and 16 for raw scores, and between -16 and 32 when certainty wheighted in.

    Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.

  3. Patient Health Questionnaire-4

    The Patient Health Questionnaire-4 is a short self-report screening tool that consists of two questions about depressive symptoms and two questions about anxiety symptoms. It combines the first two questions in Patient Health Questionnaire-9 and the first two questions in the Generalized Anxiety Disorder-7 item scale. The items are answered on a scale from 0 to 3. Higher scores reflect more symptoms of depression and anxiety. Total score ranges between 0 and 12.

    Time frame: Used as a weekly measure of depression and anxiety during the treatment weeks. This questionnaire is only planned to be used for monitoring the participants' well-being, thus, it will not be included in the result analysis.

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for May 2028, 28 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 28 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Feb 6, 2026
StartActual
Jan 14, 2026
Primary completionEst.
May 31, 2028
CompletionEst.
May 31, 2028
Last update
Feb 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07391540
Responsible party
Gerhard Andersson (Professor, Linkoeping University) — Principal investigator
First posted
Feb 6, 2026
Start date
Jan 14, 2026
Primary completion
May 31, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Feb 6, 2026

Study contacts

Gerhard Andersson, PhD
Contact
gerhard.andersson@liu.se
+46-13285840
Victoria Aminoff
Contact
victoria.aminoff@liu.se
+4613281948

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion